COMPARATIVE STEADY-STATE BIOAVAILABILITY OF CONVENTIONAL AND CONTROLLED-RELEASE FORMULATIONS OF ALBUTEROL

被引：18
|
作者：
POWELL, ML
WEISBERGER, M
DOWDY, Y
GURAL, R
SYMCHOWICZ, S
PATRICK, JE
机构：
[1] SCHERING PLOUGH CORP,DEPT DRUG METAB & PHARMACOKINET,60 ORANGE ST,BLOOMFIELD,NJ 07003
[2] SCHERING PLOUGH CORP,DEPT CLIN PHARMACOL,BLOOMFIELD,NJ 07003
来源：
BIOPHARMACEUTICS & DRUG DISPOSITION | 1987年 / 8卷 / 05期
关键词：
D O I：
10.1002/bdd.2510080506
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：461 / 468
页数：8
相关论文
共 50 条
  • [31] Comparative bioavailability study of two controlled-release pentoxifylline tablet preparations
    Yuen, KH
    Wong, JW
    Peh, KK
    Julianto, T
    Choy, WP
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (07) : 803 - 807
  • [32] CONTROLLED-RELEASE FORMULATIONS OF PROPRANOLOL AND VERAPAMIL
    DUNN, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (01): : 22 - 31
  • [33] FORMULATIONS FOR CONTROLLED-RELEASE OF FENITROTHION IN WATER
    KASSEM, SMI
    SALEH, MS
    ALY, MI
    ELLATIF, MEA
    INSECT SCIENCE AND ITS APPLICATION, 1985, 6 (05): : 613 - 616
  • [34] PHARMACOKINETIC CHARACTERIZATION OF CONTROLLED-RELEASE FORMULATIONS
    STEINIJANS, VW
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) : 173 - 181
  • [35] BUTRIPTYLINE - HUMAN PHARMACOKINETICS AND COMPARATIVE BIOAVAILABILITY OF CONVENTIONAL AND SUSTAINED-RELEASE FORMULATIONS
    BOURGOUIN, J
    GAGNON, MA
    ELIE, R
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (02) : 123 - 130
  • [36] PHARMACOKINETIC STUDY IN STEADY-STATE OF SUSTAINED-RELEASE FORMULATIONS OF THEOPHYLLINE
    PEZOA, R
    GAI, MN
    GUTIERREZ, C
    ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1987, 20 (02): : R238 - R238
  • [37] PHARMACODYNAMIC PROFILE OF VERAPAMIL IN RELATION TO ABSOLUTE BIOAVAILABILITY - INVESTIGATIONS WITH A CONVENTIONAL AND A CONTROLLED-RELEASE FORMULATION
    HARDER, S
    THURMANN, P
    SIEWERT, M
    BLUME, H
    HUBER, T
    RIETBROCK, N
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (02) : 207 - 212
  • [38] TRAZODONE CONVENTIONAL AND CONTROLLED-RELEASE FORMULATIONS - PHARMACODYNAMIC EFFECTS AFTER SINGLE AND REPEATED ADMINISTRATION
    DEBBAS, NMG
    ANKIER, SI
    WARRINGTON, SJ
    CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (08) : 501 - 509
  • [39] DETERMINATION OF BIOAVAILABILITY OF DIAZEPAM IN VARIOUS FORMULATIONS FROM STEADY-STATE PLASMA CONCENTRATION DATA
    BERLIN, A
    AGURELL, S
    STROM, S
    SIWERS, B
    SJOQVIST, F
    HIORT, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1972, 13 (05) : 733 - &
  • [40] BIOAVAILABILITY OF REGULAR AND CONTROLLED-RELEASE CHLORPHENIRAMINE PRODUCTS
    KOTZAN, JA
    VALLNER, JJ
    STEWART, JT
    BROWN, WJ
    VISWANATHAN, CT
    NEEDHAM, TE
    DIGHE, SV
    MALINOWSKI, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) : 919 - 923
12345